⌘K

Login Start Free

Home/Filings/4/0001144204-16-076472

4//SEC Filing

CASI Pharmaceuticals, Inc. 4

Accession 0001144204-16-076472

CIK 0000895051operating

View on SEC.gov Company Profile

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 2:43 PM ET

Size

9.8 KB

Accession

0001144204-16-076472

Insider Transaction Report

Form 4

Period: 2016-01-19

CASI Pharmaceuticals, Inc.CASI

COO & General Counsel

Transactions

Purchase
Common Stock
2016-01-19$0.75/sh+400$299→ 1,385 total
Purchase
Common Stock
2016-01-19$0.72/sh+4,163$2,993→ 5,948 total
Purchase
Common Stock
2016-01-19$0.75/sh+400$300→ 1,785 total
Purchase
Common Stock
2016-01-19$0.72/sh+11,837$8,519→ 17,785 total

Holdings

Common Stock
(indirect: By Spouse)
74,982

Documents

1 file

4
v429405_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000895051

Filing Metadata

Form type: 4
Filed: Jan 20, 7:00 PM ET
Accepted: Jan 21, 2:43 PM ET
Size: 9.8 KB

View on SEC.gov